Brief: Epirus Biopharmaceuticals acquires Bioceros

Epirus Biopharmaceuticals

09/09/2015 11:00

Sept 9 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * Expands biosimilar pipeline and capabilities through acquisition of bioceros 
 * Says deal valued at $14.1 million 
 * Has acquired bioceros for cash and stock payable in installments over a 
   one-year period 
 * Says announced an agreement for the acquisition of bioceros holding b.v. 
 * Anticipated filing dates for the three new pipeline products are 2020 for 
   bow080, 2021 for bow090 and 2022 for bow100 
 
 * Source text for Eikon  ID:nGNXLYAIOa  
 
 * Further company coverage  EPRS.O  ((Bengaluru Newsroom; +1 646 223 8780))